Customer Publication

Discrimination between Breast Cancer Cells and White Blood Cells by Non-Invasive Measurements: Implications for a Novel In Vitro-Based Circulating Tumor Cell Model Using Digital Holographic Cytometry

Authors: Z. El-Schich et al.

Journal: Applied Sciences (2020)

Institution: Malmö University

Research Areas: Cancer research

Cell Lines: Jurkat, THP-1, Hs-578T, MDA-MD-231, MDA-MB-468, T57D, Cama-1, MCF-7 (Jurkat - human T-cell acute lymphoblastic leukemia; THP-1 - human monocytic cell line; Hs-578T - human mammary gland carcinoma MDA-MB-231 - Human mammary carcinoma cell line; MDA-MB-468 - Human mammary carcinoma cell line; T57D - Human mammary carcinoma cell line; Cama-1 - Human breast cancer cell line; MCF-7 breast cancer cell line)

Summary: Circulating Tumor Cells (CTC) are the main cause of cancer metastasis and regeneration. However, at the moment there is a lack of methods capable to detect and isolate CTC, as they are rare and heterogeneous. In this work, Z. El-Scich with colleagues have studied the morphological differences between white blood cell lines and human breast cancer cell lines. Authors have utilized HoloMonitor M4 and results show that there are significant differences in cell size-related parameters (cell area, cell volume, and cell thickness) between white blood cell lines and breast cancer cell lines, implying that HoloMonitor M4 and digital holographic cytometry can become a powerful diagnostic tool to characterize and detect CTCs in the blood.

Keywords: HoloMonitor M4, cell morphology, breast cancer; cell area; cell thickness; cell volume; circulating tumor cell; CD45; digital holographic cytometry; EpCAM

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
Sweden
+46 46 38 60 80
info@phiab.se

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
USA
+1 617-963-5150
info@phiab.com

Invoicing

VAT: SE556542781101
faktura@phiab.se

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2